Viveve Medical, Inc. (VIVE): Price and Financial Metrics


Viveve Medical, Inc. (VIVE): $2.61

0.05 (+1.95%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

VIVE POWR Grades


  • Growth is the dimension where VIVE ranks best; there it ranks ahead of 79.36% of US stocks.
  • The strongest trend for VIVE is in Momentum, which has been heading down over the past 31 weeks.
  • VIVE ranks lowest in Quality; there it ranks in the 4th percentile.

VIVE Stock Summary

  • With a market capitalization of $27,114,793, Viveve Medical Inc has a greater market value than only 4.69% of US stocks.
  • The volatility of Viveve Medical Inc's share price is greater than that of 93.94% US stocks with at least 200 days of trading history.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for VIVE comes in at -130.53% -- higher than that of just 1.97% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Viveve Medical Inc, a group of peers worth examining would be CLSN, ABEO, MRAM, KALA, and ECOR.
  • Visit VIVE's SEC page to see the company's official filings. To visit the company's web site, go to www.viveve.com.

VIVE Valuation Summary

  • In comparison to the median Healthcare stock, VIVE's price/earnings ratio is 103.24% lower, now standing at -1.1.
  • Over the past 137 months, VIVE's EV/EBIT ratio has gone up 1.1.
  • Over the past 137 months, VIVE's price/sales ratio has gone up 4.4.

Below are key valuation metrics over time for VIVE.

Stock Date P/S P/B P/E EV/EBIT
VIVE 2018-11-08 5.4 -37.0 -2.2 -2.6
VIVE 2016-05-09 41.4 15.2 -4.8 -4.8
VIVE 2015-12-14 53.4 19.2 -3.7 -3.7
VIVE 2015-01-28 28.9 14.0 7.3 5.5
VIVE 2014-10-31 2.1 -0.2 0.4 1.7
VIVE 2014-06-16 1.2 -0.1 0.1 0.6

VIVE Growth Metrics

  • Its 3 year revenue growth rate is now at 562.09%.
  • Its 5 year cash and equivalents growth rate is now at 49.18%.
  • Its 2 year net income to common stockholders growth rate is now at 6.42%.
Over the past 34 months, VIVE's revenue has gone down $12,770,000.

The table below shows VIVE's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-03-31 5.625 -12.751 -25.674
2020-12-31 5.479 -15.234 -26.064
2020-09-30 4.983 -18.31 -35.42
2020-06-30 4.511 -22.171 -38.588
2020-03-31 4.859 -25.414 -40.176
2019-12-31 6.567 -31.236 -42.906

VIVE Price Target

For more insight on analysts targets of VIVE, see our VIVE price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $9.63 Average Broker Recommendation 1.25 (Strong Buy)

VIVE Stock Price Chart Interactive Chart >

Price chart for VIVE

VIVE Price/Volume Stats

Current price $2.61 52-week high $14.40
Prev. close $2.56 52-week low $2.40
Day low $2.54 Volume 28,529
Day high $2.67 Avg. volume 1,062,935
50-day MA $2.70 Dividend yield N/A
200-day MA $3.67 Market Cap 27.65M

Viveve Medical, Inc. (VIVE) Company Bio


Viveve Medical, Inc. designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal laxity. The company was founded in 2005 and is based in Sunnyvale, California.


VIVE Latest News Stream


Event/Time News Detail
Loading, please wait...

VIVE Latest Social Stream


Loading social stream, please wait...

View Full VIVE Social Stream

Latest VIVE News From Around the Web

Below are the latest news stories about Viveve Medical Inc that investors may wish to consider to help them evaluate VIVE as an investment opportunity.

Viveve Announces New Category III CPT Code for its Stress Urinary Incontinence Procedure

New code approved by American Medical Association and supported by key medical societiesLong-term pathway for potential reimbursement now established for Company's dual-energy noninvasive treatment for urethral hypermobility to improve stress urinary incontinence in womenENGLEWOOD, CO / ACCESSWIRE / July 7, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that the American Medical Association (AMA) has issued a new Catego

Yahoo | July 7, 2021

Viveve to Participate in Ladenburg Thalmann Healthcare Virtual Conference

ENGLEWOOD, CO / ACCESSWIRE / July 6, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive officer, will participate in the Ladenburg Thalmann Healthcare Conference, July 13 - 14, 2021.

Yahoo | July 6, 2021

Viveve Medical, Inc.: Viveve Announces Issuance of New Device and Methods Patent in U.S.

ENGLEWOOD, CO / ACCESSWIRE / June 10, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women''s intimate health, today announced that the United States Patent and T

FinanzNachrichten | June 10, 2021

Viveve Announces Issuance of New Device and Methods Patent in U.S.

ENGLEWOOD, CO / ACCESSWIRE / June 10, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that the United States Patent and Trademark Office (USPTO) recently issued U.

Yahoo | June 10, 2021

Viveve Medical, Inc.: Viveve Reports First Quarter 2021 Financial Results and Provides Corporate Update

Pivotal SUI PURSUIT trial enrollment underway and accelerating Total revenue of $1.5M for Q1 including sale of 2,450 consumable treatment tips Strengthened patent portfolio in key Asia Pacific mark

FinanzNachrichten | May 13, 2021

Read More 'VIVE' Stories Here

VIVE Price Returns

1-mo -10.92%
3-mo -14.71%
6-mo -30.95%
1-year -54.95%
3-year -99.87%
5-year -99.96%
YTD -44.47%
2020 -62.70%
2019 -98.80%
2018 -78.87%
2017 -3.50%
2016 N/A

Continue Researching VIVE

Want to see what other sources are saying about Viveve Medical Inc's financials and stock price? Try the links below:

Viveve Medical Inc (VIVE) Stock Price | Nasdaq
Viveve Medical Inc (VIVE) Stock Quote, History and News - Yahoo Finance
Viveve Medical Inc (VIVE) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8471 seconds.